Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.
Houston will produce Foundayo ingredients, linking manufacturing capacity directly to Lilly's planned global rollout.
Lilly begins hiring: Eli Lilly is actively recruiting for its $6.5 billion manufacturing site in Houston, signaling immediate opportunities for applicants. PCI facilities opening: PCI Pharma Services ...
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts." ...
The FDA has approved Eli Lilly's Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin indicated alongside diet and exercise to control high blood sugar in adults with ...
The average long-term U.S. mortgage rate rose this week above 7% for the first time since January 2025, the latest affordability setback for prospective homebuyers following a five-week run of ...
More than 83 tons of meat are being recalled across the country because the products were not properly inspected by federal authorities and were shipped out with false inspection stickers. The ...
Eli Lilly says 700,000 US seniors started GLP-1 treatment through Medicare's Bridge scheme, with taxpayers covering about $195 per patient each month.
The U.S. now accounts for more than half of Novo Nordisk’s revenue.
Governor Greg Abbott delivered remarks at the groundbreaking ceremony for Eli Lilly and Company’s $6.5 billion active ...
Das geplante Houstoner Werk soll Medikamente herstellen und künstliche Intelligenz direkt in Fertigungsprozesse integrieren.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results